These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 3264374

  • 21. [Leprosy - An overview from a pediatric perspective].
    Magdorf K, Haas WH, Harms D, Höger PH, Griese M, Rank M.
    Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524
    [Abstract] [Full Text] [Related]

  • 22. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Leprosy in The Netherlands in the period 1970-1991].
    Post E, chin-A-Lien RA, Bouman C, Naafs B, Faber WR.
    Ned Tijdschr Geneeskd; 1994 Sep 24; 138(39):1960-3. PubMed ID: 7935946
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Leprosy in HIV infection: a study of three cases.
    Rath N, Kar HK.
    Indian J Lepr; 2003 Sep 24; 75(4):355-9. PubMed ID: 15242274
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A.
    Lepr Rev; 2005 Jun 24; 76(2):182-3. PubMed ID: 16038255
    [No Abstract] [Full Text] [Related]

  • 30. Lack of response to WHO/MDT; a case report by Habtemariam and Xabier.
    Pannikar VK.
    Int J Lepr Other Mycobact Dis; 1994 Sep 24; 62(3):443-4. PubMed ID: 7963922
    [No Abstract] [Full Text] [Related]

  • 31. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1992 Sep 24; 60(3):421-35. PubMed ID: 1474281
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ocular leprosy in Kenya.
    Adala HS, Kagame K.
    East Afr Med J; 1988 Sep 24; 65(9):593-601. PubMed ID: 3265663
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M, Saunderson PR, Gelber RH.
    Lepr Rev; 2011 Sep 24; 82(3):213-21. PubMed ID: 22125929
    [Abstract] [Full Text] [Related]

  • 37. Tuberculosis and Leprosy: Classical Granulomatous Diseases in the Twenty-First Century.
    Scollard DM, Dacso MM, Abad-Venida ML.
    Dermatol Clin; 2015 Jul 24; 33(3):541-62. PubMed ID: 26143431
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy.
    Moubasher AD, Kamel NA, Zedan H, Raheem DD.
    Int J Dermatol; 1998 Oct 24; 37(10):741-6. PubMed ID: 9802683
    [Abstract] [Full Text] [Related]

  • 40. Paucibacillary treatment for large tuberculoid lesions of leprosy?
    Santos MN, de Ferreira LC, Talhari S.
    Int J Lepr Other Mycobact Dis; 2005 Sep 24; 73(3):225-7; author reply 227-8. PubMed ID: 16830649
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.